Cargando…
Clinical Profile and Treatment Outcomes of Amblyopia Across Age Groups
PURPOSE: The purpose is to study the clinical profile of amblyopia by age at diagnosis. SUBJECTS AND METHODS: A retrospective chart review of 327 amblyopic patients over 7 years (September 2009–December 2016) was performed, divided by age at diagnosis into four groups: <3, 3–7, 8–15, and >15 y...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6737791/ https://www.ncbi.nlm.nih.gov/pubmed/31543663 http://dx.doi.org/10.4103/meajo.MEAJO_182_17 |
_version_ | 1783450723813425152 |
---|---|
author | Al-Haddad, Christiane Ismail, Karine Jurdi, Kheir Wajiha Keaik, Mona |
author_facet | Al-Haddad, Christiane Ismail, Karine Jurdi, Kheir Wajiha Keaik, Mona |
author_sort | Al-Haddad, Christiane |
collection | PubMed |
description | PURPOSE: The purpose is to study the clinical profile of amblyopia by age at diagnosis. SUBJECTS AND METHODS: A retrospective chart review of 327 amblyopic patients over 7 years (September 2009–December 2016) was performed, divided by age at diagnosis into four groups: <3, 3–7, 8–15, and >15 years. Demographics, eye conditions and eye examination parameters including visual acuity (VA), refractive errors, and motility measurements were collected. RESULTS: Mean age at diagnosis and follow-up time was 6.2 ± 6.1 years standard deviation (SD) and 12.4 months ± 20.6 SD, respectively. The most common overall cause of amblyopia was strabismus (37%) followed by anisometropia (36%). The main causes by age at diagnosis were: strabismus at <3 years, anisometropia at 3–7 years, anisometropia at 8–15 years, and mixed at >15 years. Significant improvement in VA with treatment was noted with age between 3 and 15 years (3–7 years, P = 0.001 and 8–15 years, P = 0.03). CONCLUSIONS: Strabismus was the main cause of amblyopia at <3 years of age; anisometropia was more prevalent in older children (3–15 years). The fact that more than a quarter of our amblyopic patients were detected late (after the age of 8 years) underscores the need for expanded vision screening measures in young children. |
format | Online Article Text |
id | pubmed-6737791 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Wolters Kluwer - Medknow |
record_format | MEDLINE/PubMed |
spelling | pubmed-67377912019-09-20 Clinical Profile and Treatment Outcomes of Amblyopia Across Age Groups Al-Haddad, Christiane Ismail, Karine Jurdi, Kheir Wajiha Keaik, Mona Middle East Afr J Ophthalmol Original Article PURPOSE: The purpose is to study the clinical profile of amblyopia by age at diagnosis. SUBJECTS AND METHODS: A retrospective chart review of 327 amblyopic patients over 7 years (September 2009–December 2016) was performed, divided by age at diagnosis into four groups: <3, 3–7, 8–15, and >15 years. Demographics, eye conditions and eye examination parameters including visual acuity (VA), refractive errors, and motility measurements were collected. RESULTS: Mean age at diagnosis and follow-up time was 6.2 ± 6.1 years standard deviation (SD) and 12.4 months ± 20.6 SD, respectively. The most common overall cause of amblyopia was strabismus (37%) followed by anisometropia (36%). The main causes by age at diagnosis were: strabismus at <3 years, anisometropia at 3–7 years, anisometropia at 8–15 years, and mixed at >15 years. Significant improvement in VA with treatment was noted with age between 3 and 15 years (3–7 years, P = 0.001 and 8–15 years, P = 0.03). CONCLUSIONS: Strabismus was the main cause of amblyopia at <3 years of age; anisometropia was more prevalent in older children (3–15 years). The fact that more than a quarter of our amblyopic patients were detected late (after the age of 8 years) underscores the need for expanded vision screening measures in young children. Wolters Kluwer - Medknow 2019-08-26 /pmc/articles/PMC6737791/ /pubmed/31543663 http://dx.doi.org/10.4103/meajo.MEAJO_182_17 Text en Copyright: © 2019 Middle East African Journal of Ophthalmology http://creativecommons.org/licenses/by-nc-sa/4.0 This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. |
spellingShingle | Original Article Al-Haddad, Christiane Ismail, Karine Jurdi, Kheir Wajiha Keaik, Mona Clinical Profile and Treatment Outcomes of Amblyopia Across Age Groups |
title | Clinical Profile and Treatment Outcomes of Amblyopia Across Age Groups |
title_full | Clinical Profile and Treatment Outcomes of Amblyopia Across Age Groups |
title_fullStr | Clinical Profile and Treatment Outcomes of Amblyopia Across Age Groups |
title_full_unstemmed | Clinical Profile and Treatment Outcomes of Amblyopia Across Age Groups |
title_short | Clinical Profile and Treatment Outcomes of Amblyopia Across Age Groups |
title_sort | clinical profile and treatment outcomes of amblyopia across age groups |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6737791/ https://www.ncbi.nlm.nih.gov/pubmed/31543663 http://dx.doi.org/10.4103/meajo.MEAJO_182_17 |
work_keys_str_mv | AT alhaddadchristiane clinicalprofileandtreatmentoutcomesofamblyopiaacrossagegroups AT ismailkarine clinicalprofileandtreatmentoutcomesofamblyopiaacrossagegroups AT jurdikheirwajiha clinicalprofileandtreatmentoutcomesofamblyopiaacrossagegroups AT keaikmona clinicalprofileandtreatmentoutcomesofamblyopiaacrossagegroups |